Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines

Uveal melanoma is the most common primary malignancy of the eye in adults. Despite significant improvements in treatment of the primary tumor, to date none of these therapies prevent metastatic disease or improve overall survival. We are exploring immunotherapeutic options for metastatic uveal melan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kittler, Julia M., Sommer, Jonas, Fischer, Anika, Britting, Sabine, Karg, Margarete M., Bock, Barbara, Atreya, Imke, Heindl, Ludwig M., Mackensen, Andreas, Bosch, Jacobus J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442993/
https://www.ncbi.nlm.nih.gov/pubmed/30956760
http://dx.doi.org/10.18632/oncotarget.26737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442993/
https://www.ncbi.nlm.nih.gov/pubmed/30956760
http://dx.doi.org/10.18632/oncotarget.26737

Ejemplares similares